BUZZ-Incyte 上调血癌药物销售预期后股价上涨

路透中文
Jul 29, 2025
BUZZ-Incyte 上调血癌药物销售预期后股价上涨

7月29日 - ** 制药商IncyteINCY.O股价盘前上涨4.5%至73.3美元

** INCY将其血癌治疗药物Jakafi的年销售额预期从之前的29.5亿至30亿美元上调至30亿至30.5亿美元。

** 根据LSEG汇编的数据,公司第二季度调整后每股利润为1.57美元 ,高于分析师预计的每股1.47美元

** 本季度总营收为12.2亿美元,高于预期的11.5亿美元

** 截至收盘,股价累计上涨 1.6

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10